Congenital heart disease is the most common birth defect in the United States, occurring in one of every 110 births. Due to medical breakthroughs and progress in treatment, patients with CHD are reaching adulthood and living longer. Currently, there are more than one million adults in the United States living with this disease, and this number continues to rise by approximately 5 percent each year. At least 10 percent of all congenital heart defects are first detected in adulthood. Take advantage of this opportunity to have your questions answered by Richard Krasuski, MD, Director of Cleveland Clinic’s Adult Congenital Disease Center.
Richard Krasuski, MD is the Director of Adult Congenital Heart Disease Center and a staff cardiologist in the Section of Clinical Cardiology, the Robert and Suzanne Tomsich Department of Cardiovascular Medicine, at the Sydell and Arnold Miller Family Heart & Vascular Institute at Cleveland Clinic.
He is certified by the American Board of Internal Medicine as Diplomate in cardiovascular disease. Dr. Krasuski's specialty interests include adult congenital heart disease including atrial septal defects, patent foramen ovale, ventricular septal defects, coarctation of the aorta, Ebstein anomaly, Eisenmenger syndrome, transposition of the great arteries, tetralogy of Fallot and patent ductus arteriosus. He also specializes in pulmonary hypertension, mitral valve disease, cardiac catheterization, transesophageal echocardiography and mitral, aortic and pulmonic valvuloplasty.
Dr. Krasuski has served as an abstract reviewer for the American College of Cardiology and has chaired various oral sessions in the past. Presently, he is either a reviewer or serves on the editorial board of several leading medical publications including Journal of the American Medical Association, Journal of the American College of Cardiology, Circulation, American Journal of Cardiology, Annals of Internal Medicine, Heart, American Journal of Managed Care, American Journal of Medicine, Advances in Pulmonary Hypertension and American Heart Journal.
He has authored or co-authored articles and abstracts related to his specialty interests in leading medical journals such as the Journal of the American Medical Association, Journal of the American College of Cardiology, Circulation, and Annals of Internal Medicine.
Dr. Krasuski is a Fellow both of the American College of Cardiology (FACC) and the American Heart Association (FAHA), and a member of the Adult Congenital Heart Association, the International Society for Adult Congenital Heart Disease, the Pulmonary Hypertension Clinicians and Researchers Society of the Pulmonary Hypertension Association and the Massachusetts Medical Society.